Thus, to the best of our knowledge, there is only one publication reporting MYCL in localized PC [41], where they identified and validated a new recurring MYCL amplification, which is associated with TP53 deletion and unique profiles of DNA damage and transcriptional dysregulation. The gene discussed is TP53; the disease is pachyonychia congenita.